China Cord Blood reported 161.61M in EBITDA for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Cerus CERS:US $ -8.98M 2.83M
China Cord Blood CO:US 161.61M 11.22M
Cytori Therapeutics CYTX:US $ -3.78M 0.27M
Enzo Biochem ENZ:US $ -1.67M 3.3M
Mednax MD:US $ 49.3M 29.62M